Catalyst
Slingshot members are tracking this event:
Tesaro (TSRO) to Determine Potential Registration Strategy for Niraparib + TSR-042 in Ovarian Cancer and Other Cancers in 2H 2017
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| TSRO |
|
|
||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Jun 03, 2017
Occurred Source:
http://ir.tesarobio.com/releasedetail.cfm?ReleaseID=1028914
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Registration Strategy, Niraparib, Tsr-042, Ovarian Cancer, Other Cancers
